Ongoing Clinical Trials

  • A Single-center, Randomized, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Dose of AP303 Following Oral Administration, and the Effect of Food on the Pharmacokinetics of AP303 in Healthy Subjects
  • A Phase 2, Randomized, Open-Label, Active-Controlled, Multicenter Study to Evaluate the Safety and Serum Phosphorus Lowering Effect of AP-306 in Chronic Kidney Disease Patients Receiving Maintenance Hemodialysis With Hyperphosphatemia

Completed Clinical Trials

  • A Phase 2 Study to Evaluate the Safety and Efficacy of Escalated and Fixed Doses of AP301 in Comparison With Sevelamer Carbonate to Treat Hyperphosphatemia in Chronic Kidney Disease Patients Receiving Hemodialysis